July 18 (Reuters) - Diamedica Inc DMA.V
* Intends to use offering proceeds toward advancing its research and development programs including an upcoming dm199 clinical trial, general corporate purposes
* Diamedica announces strategic investment by hermed capital healthcare fund
* Agreement provides for hermed capital to invest $4 million for a total of 20 million shares of co at $0.20/common share in two tranches Source text for Eikon: nMKW8wBG9a Further company coverage: DMA.V
(Bengaluru Newsroom +91 80 6749-1130; within U.S. +1 646 223 8780)